Stat3 mediates cellular responses associated with proliferation, survival and differentiation, but the mechanisms underlying the diverse effects of this signaling molecule remain unknown. M1 mouse myeloid leukemia cells arrest growth and differentiate into macrophages following treatment with interleukin 6 (IL-6) or leukemia inhibitory factor (LIF), and recent studies have shown that Stat3 plays a central role in this process. Utilizing representational difference analysis, we demonstrate that expression of the mouse BATF gene is upregulated as an early response to IL-6/LIF stimulation and Stat3 activation in this cell system. Immunoblots using antibodies to BATF detected an increase in BATF protein in response to LIF/IL-6 stimulation. BATF is a member of the AP-1 family of basic leucine zipper transcription factors and functions to inhibit the transcriptional and biological functions of AP-1 activity in mammalian cells. BATF forms complexes with c-Jun in M1 cells and forced expression of BATF in the absence of Stat3 signaling results in a reduced rate of cellular growth. These results indicate that Stat3 mediates cellular growth by modulating AP-1 activity through the induction of BATF. Oncogene (2002 Oncogene ( ) 21, 8186 -8191. doi:10.1038 Keywords: IL-6/LIF; gp130; Stat3; BATF; AP-1 Members of the interleukin-6 (IL-6) cytokine family, which include leukemia inhibitory factor (LIF), ciliary neurotrophic factor (CNTF), oncostatin M (OSM), interleukin-11 (IL-11) and cardiotrophin-1 (CT-1) regulate cell growth, survival and differentiation and are involved in variety of biological responses, including the immune response, inflammation, hematopoiesis and oncogenesis. These cytokines use gp130 as a common receptor subunit. The binding of ligands to gp130 activates the JAK/Stat signal transduction pathway where Stat3 plays a central role in transmitting signals from the membrane to the nucleus .
An increasing number of candidate target genes of Stat3 have been characterized and many of these genes encode proteins that regulate cell cycle progression and/or modulate the apoptotic response. The expression of positive cell cycle regulatory genes such as cyclin D1/D2/D3/A, cdc25A, c-myc, pim-1, bcl-2 and bcl-x are up-regulated by Stat3 activation (Fukada et al., 1996 Bromberg et al., 1999; Shirogane et al., 1999) . In contrast, Stat3 has been shown to contribute to cell cycle arrest by inducing the expression of cyclindependent kinase inhibitors such as p19 INK4D and p21 CIP1 (Bellido et al., 1998; O'Farrell et al., 2000) . The cellular circumstances, as well as the precise molecular mechanisms, underlying the diverse signaling effects described for Stat3 have yet to be determined.
To identify the genes involved in signal transduction via gp130, we have performed representational difference analysis (RDA) using M1 cells which differentiate into macrophages upon Stat3 activation by LIF/IL-6 (Lisitsyn et al., 1993; Hubank et al., 1994) . Recently, we reported that the Ral guanine nucleotide dissociation stimulator, RalGDS, was induced in this system in a manner dependent on Stat3 activation (Senga et al., 2001) . We have analysed an additional 85 differentially represented DNA fragments and found that eight corresponded to the mouse BATF cDNA. BATF is a 125 amino acid nuclear basic leucine zipper protein and a member of the AP-1 family of transcription factors (Dorsey et al., 1995) . BATF forms DNA binding heterodimers with Jun proteins and negatively regulates AP-1 mediated transcription in vitro and in vivo (Dorsey et al., 1995; Echlin et al., 2000; Williams et al., 2001) . While the physiological function of BATF is still unknown, the fact that BATF is restricted to hematopoietic tissues suggests a role for the protein in myeloid and/or lymphoid lineage development. To confirm that BATF mRNA is induced upon LIFstimulation, we examined expression by RNA blot analysis. BATF mRNA was induced 1 h after LIFstimulation, peaked at 3 h and declined thereafter ( Figure 1a) . Stimulation of M1 cells with IL-6 had the same effect (Figure 1b) . Transcription of JDP-1 and JDP-2 -genes that encode proteins functionally related to BATF by their ability to bind c-Jun and inhibit AP-1 activity (Aronheim et al., 1997) were not induced by LIF-stimulation ( Figure 1c ). We also examined the induction of BATF mRNA in the 32D mouse cell line and mouse ES cells. While 32D cells differentiate upon Stat3 activation by G-CSF in the absence of IL-3, ES cells proliferate in response to cytokines that activate Stat3. Induction of BATF mRNA was seen in 32D, but not in ES cells (Figure 1d ), suggesting that the BATF mRNA induction is a feature of cells undergoing growth arrest in response to Stat3 signaling. The observed increase in BATF transcripts is reflected in an increase in BATF protein. Using polyclonal antibodies raised to mouse BATF and reactive with exogenously expressed Myc-tagged BATF in COS7 cells (Figure 1e ), we detected increased expression of BATF in M1 cells 6h after LIF-stimulation which returned to basal levels by 12 h (Figure 1f ).
To investigate whether the induction of BATF mRNA was dependent on Stat3 activation, we analysed BATF transcripts in M1 cells expressing a dominant-negative form of Stat3 (Y705F) or a JAK inhibitor (JAB /SOCS1/SSI-1) (Masuhara et al., 1997) . When stimulated with LIF, both M1/Y705F and M1/ JAB cells showed much weaker phosphorylation of tyrosine 705 of Stat3 than parental M1 cells ( Figure  2a ). Corresponding to the depressed levels of Tyr705 phosphorylation, the induction of BATF mRNA also was reduced ( Figure 2b ). We also generated M1 cells expressing Stat3 fused with the estrogen receptor (M1/ Stat3ER). In these cells, Stat3 is conditionally active following stimulation with 4-hydroxytamoxifen (4HT) (Matsuda et al., 1999) . Stimulation of M1/Stat3ER with 4HT induced BATF mRNA (Figure 2c ). Together, these data strongly suggest that the induction of BATF mRNA is dependent on the activation of the JAK/Stat3 signaling pathway.
In addition to the JAK/Stat3 pathway, LIF/IL-6 also activates the SHP-2/Grb2/MAP kinase pathway through gp130 (Fukada et al., 1996; Takahashi-Tezuka et al., 1998) . Therefore, we examined the possibility that the induction of BATF might require the activity of MAP kinase. As shown in Figure 3a , MAP kinase was activated in M1 cells upon LIF-stimulation and the MEK inhibitor, PD98059, inhibited this activation. Interestingly, PD98059 had no effect on the induction of BATF mRNA (Figure 3b ), suggesting that signaling via SHP-2/Grb2/MAP kinase does not play a major role in the up-regulation of BATF. M1 cells were stimulated with LIF in the presence of cyclohexamide (CHX) to examine whether BATF induction required de novo protein synthesis. As shown in Figure 3c , CHX treatment did not affect BATF mRNA accumulation, suggesting that BATF is likely to be a direct transcriptional target of Stat3.
To examine the biological impact of BATF protein induction in M1 cells, a Myc-tagged BATF expression vector was introduced into M1 cells to establish cell lines (M1/BATF 1 and 2). As a control, a cell line expressing the neomycin resistance gene alone was produced (M1/neo). Immunoblot analysis revealed that the level of Myc-BATF expressed in these cell lines was Full-length mouse BATF fused to GST was used to immunize a rabbit. Anti-BATF antibodies were purified using GST-BATF coupled to a HiTrap NHS-activated HP column (Amersham Pharmacia Biotech). COS7 cells were transfected with pcDNA3/ Myc-tagged BATF and protein extracts analysed by immunoblotting. (f) M1 cells were stimulated for the times indicated and cell lysates were immunoblotted with anti-BATF antibodies approximately three times greater than the level induced by LIF stimulation (Figure 4a ). The morphology of cells was indistinguishable from that of parental M1 cells. To examine if forced expression of BATF accelerated the differentiation of M1 cells, additional genes whose expression is altered by LIF-induced differentiation in this system (Selvakumaran et al., 1992; Lord et al., 1993) were examined. Expression of BATF did not change the repression of myc and myb genes, nor the induction of cd11b gene by LIF (data not shown). The growth kinetics of M1/BATF1 and 2 cells were analysed and the results showed that the growth rates of these cells were reduced to about one half of that of M1/neo control cells (Figure 4b ). Cell cycle analysis revealed that the number of cells in the G1 phase of the cell cycle was increased in M1/BATF1 and 2 cells relative to controls (Figure 4c ). Since BATF is thought to inhibit AP-1 activity through its interaction with Jun proteins (Echlin et al., 2000) , we investigated if introduction of exogenous c-Fos to M1/ BATF cells might increase cell growth. Indeed, when cFos was introduced to M1/BATF1 and 2 cells, growth increased (Figure 4b ).
Since it has been reported that BATF binds to c-Jun in vitro (Echlin et al., 2000) , we examined if this intermolecular interaction was occurring in M1 cells. The Myc-BATF expressed in M1/BATF1 cells was immunoprecipitated with anti-Myc antibody and the proteins resolved by SDS -PAGE were immunoblotted with an anti-c-Jun antibody. Results show the presence of significant amounts of c-Jun in the BATF complex (Figure 4d ). We also tested if endogenous BATF interacted with c-Jun. M1 cells were stimulated with LIF and BATF was immunoprecipitated with the anti-BATF antibody. As shown in Figure 4e , immunoblot analysis of the proteins co-precipitated with BATF using the anti-c-Jun antibody detected the presence of c-Jun in endogenous BATF complexes as well. These results are consistent with a model (Echlin et al., 2000) in which BATF reduces AP-1 activity by competing with Fos for the available intracellular pool of Jun.
To investigate if the induction of BATF results in a change to the overall levels of AP-1 activity in LIFtreated M1 cells, luciferase activity from an AP-1 reporter gene was measured over time. As shown in Figure 4f , AP-1 activity increases immediately after LIF-stimulation. This is likely due to the induction of the Jun family proteins, c-Jun and JunB, which increase rapidly and remain elevated for at least 48 h (Lord et al., 1993 ; data not shown). Interestingly, in parallel with the expression pattern of BATF, which peaks between 3 and 6 h after LIF exposure ( Figure   Figure 2 M1 cells were stimulated with LIF plus 50 mM PD98059 or (c) LIF plus 10 ng/ml cyclohexamide (CHX) and induction of BATF mRNA was examined by RNA blot hybridization 1f), there is a transient and reproducible decrease in AP-1 luciferase activity. These results support a role for BATF in modulating AP-1 transcriptional activity during these early stages of LIF-induced differentiation.
To assess the importance of BATF induction to M1 cell differentiation, we attempted to inhibit BATF expression by introducing anti-sense BATF, but achieved only a partial block of BATF protein accumulation and no obvious biological effect (data not shown). We then attempted to express BATF-TAD, a construct in which BATF is converted into a potent activator of AP-1 transcription by fusion with the transcription activation domain (TAD) of VP16 (Echlin et al., 2000) . No neo resistant M1 colonies were obtained. One possibility is that the high level of AP-1 transactivation directed by the fusion protein accelerates M1 cell differentiation and does not permit colony expansion. This conclusion is supported by studies (Lord et al., 1993) where c-Fos overexpression was shown to accelerate M1 cell differentiation in the presence of LIF. Since AP-1 luciferase activity continues to be high in M1 cells (at least up to 10 h following stimulation) (Figure 4f) , it is likely that BATF functions transiently to repress the expression of key AP-1 targets whose orderly accumulation is critical to the temporal control of differentiation in this system.
BATF is expressed predominantly in hematopoietic tissues where Stat3 is important for cell lineage specification. It has been reported that Stat3 is required for B cell differentiation into antibody-forming cells in response to the stimulation of both CD40 and gp130 Ohtani et al., 2000) . Stat3 also plays an essential role in granulocyte colony stimulating factor (G-CSF)-induced granulocyte differentiation (Shimozaki et al., 1997) . The induction of BATF was observed during the growth arrest and differentiation of 32D cells upon G-CSF stimulation. These results suggest a possible role for BATF in hematopoietic differentiation by modulating AP-1 activity.
We have shown that LIF/IL-6 induces BATF mRNA and protein in a Stat3 dependent manner. To our knowledge, this is the first report of BATF as an early response gene of cytokine stimulation. In addition, we show that BATF interacts with c-Jun in M1 cells and that expression of BATF parallels changes in the expression of an AP-1 reporter gene. Collectively, our results suggest a model in which Stat3 activation contributes to the suppression of M1 cell growth by modulating AP-1 transcription through the induction of BATF. Figure 4 (a) Myc-tagged BATF is expressed in M1 cells. Myc-tagged BATF in the PMX-neo vector was used to transfect BOSC23 cells as described previously (Kitamura and Morikawa, 2000) . Forty-eight hours later, the medium was collected and was applied to M1 cells with 10 mg/ml of hexadimethrine bromide (Sigma) for infection. Forty-eight hours after infection, cells were selected with G418 (800 mg/ml) and two clonal cell lines (M1/BATF1 and M1/BATF2) were established. Lysates of M1, M1/ BATF1, M1/BATF2 and M1/BATF1 treated with LIF for 3 h were immunoblotted with anti-BATF antibodies. (b) c-Fos in the pMX-puro vector was used to infect M1/BATF1 or M1/BATF2 cells and colonies selected with 10 mg/ml of puromycin. The growth of M1/neo, M1/BATF1, M1/BATF2, M1/BATF1/FOS and M1/BATF2/FOS was compared. 2610 5 /ml of cells of each line were plated on day 0 and cell counts determined on days 1 -3. Results represent the average of three independent experiments. (c) Cell cycle analysis of M1/neo, M1/BATF1 and M1/BATF2 cells. Cells were fixed in 75% ethanol/water, stained with propidium iodide and analysed by flow cytometry. (d) Anti-Myc antibody was used with lysates from M1/neo and M1/BATF1 cells to immunoprecipitate Myc-tagged BATF and associated proteins. Immunoprecipitates were resolved by SDS -PAGE and immunoblotted with anti-c-Jun antibody (ac-Jun) and anti-Myc antibody (aMyc). (e) M1 cells were stimulated with LIF for the times indicated and cell extracts were prepared. Proteins immunoprecipitated from the lysates using anti-BATF antibodies (aBATF) were immunoblotted with a c-Jun and a BATF. Lysates from M1 cells treated with LIF for 3 h were subjected to immunoprecipitation with pre-immune serum (P.I) as a control. (f) 1610 7 M1 cells per 100 mm plate were transiently transfected with 10 mg AP-1 Luc and 1 mg pRL-0-Luc using the QIAGEN SuperFect 1 protocol. Twenty-four hours after transfection, cells were treated with 5 ng/ml LIF for the indicated times. Cells were lysed in 160 ml passive lysis buffer and 40 ml of each used to assay for AP-1 Luc activity, normalized using the pRL-0-Luc internal control. AP-1 activity at time zero (prior to LIF treatment) was set to 1. Each time point represents the average of three separate transfections, except for the 10 h time point which was performed once. Error bars indicate the s.e.m.
